SEARCH

SEARCH BY CITATION

References

  • 1
    Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411415.
  • 2
    Goto M, Takei Y, Kawano S, Nagano K, Tsuji S, Masuda E, Nishimura Y, et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 1994; 19: 675681.
  • 3
    Okumura S, Takei Y, Kawano S, Nagano K, Masuda E, Goto M, Tsuji S, et al. Vasoactive effect of endothelin-1 on rat liver in vivo. Hepatology 1994; 19: 155161.
  • 4
    Tran-Thi T, Kawada N, Decker K. Regulation of endothelin-1 action on the perfused rat liver. FEBS Lett 1993; 318: 353357.
  • 5
    Gandhi CR, Behal RH, Harvey SAK, Nouchi TA, Olson MS. Hepatic effects of endothelin. Biochem J 1992; 287: 897904.
  • 6
    Kawamura E, Yamanaka N, Okamoto E, Tomoda F, Furukawa K. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology 1995; 21: 11381143.
  • 7
    Ihara M, Fukuroda T, Saeki T, Nishikibe M, Kojiri K, Suda H, Yano M, et al. An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis. Biochem Biophys Res Commun 1991; 178: 132137.
  • 8
    Ihara M, Noguchi K, Saeki T, Fukuroda T, Tuchida S, Kimura S, Fukami T, et al. Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci 1992; 50: 247255.
  • 9
    Sogabe K, Nirei H, Shoubo M, Nomoto A, Ao S, Notsu Y, Ono T. Pharmacological profile of FR139317, a novel, potent endothelin ETA receptor antagonist. J Pharmacol Exp Ther 1993; 264: 10401046.
  • 10
    Urade Y, Fujitani Y, Oda K, Watanabe T, Umemura I, Takai M, Okada T, et al. An endothelin B receptor-selective antagonist: IRL1038[Cys11-Cys15]-endothelin-1( 11–21). FEBS Lett 1992; 311: 1216.
  • 11
    Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, Fukuroda T, et al. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 1994; 91: 48924896.
  • 12
    Tanaka T, Tsukuda E, Nozawa M, Nonaka H, Ohono T, Kase H, Yamada K, et al. RES-701–1, a novel, potent, endothelin type B receptor-selective antagonist of microbial origin. Mol Pharmacol 1994; 45: 724730.
  • 13
    Clozel M, Gray GA, Breu V, Loffler BM, Osterwalder R. The endothelin ETB receptor mediates both vasodilatation and vasoconstriction in vivo. Biochem Biophys Res Commun 1992; 186: 867873.
  • 14
    Mcmurdo L, Corder R, Triemermann C, Vane JR. Incomplete inhibition of the pressor effects of endothelin-1 and related peptides in the anaesthetized rat with BQ-123 provides evidence for more than one vasoconstrictor receptor. Br J Pharmacol 1993; 108: 557561.
  • 15
    Kiso T, Ito S, Ohta T, Asano T, Nakazato Y. Characterization of vasoactive intestinal peptide receptors in canine liver membrane. Biochem Pharmacol 1994; 47: 241245.
  • 16
    Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with folin phenol reagent. Biol Chem 1951; 193: 265273.
  • 17
    Ikeda S, Oka JI, Nagao T. Effect of four diltiazem stereoisomers on binding of d-cis-[3H] diltiazem and (+)-[3H] PN-200–110 to rabbit T-tubule calcium channels. Eur J Pharmacol 1991; 208: 199205.
  • 18
    Weibel ER, Kistler GS, Scherle WF. Practical stereological methods for morphometric cytology. J Cell Biol 1966; 30: 2338.
  • 19
    Masaki T. Reduced sensitivity of vascular response to endothelin. Circulation 1993; 87 (suppl V): V33V35.
  • 20
    Gandhi CR, Stephenson K, Olson MS. Endothelin, a potent peptide agonist in the liver. J Biol Chem 1990; 265: 1743217435.
  • 21
    Ikeda S, Awane Y, Kusumoto K, Wakimatsu M, Watanabe T, Fuzino M. A new endothelin receptor antagonist, TAK-044, shows long-lasting inhibition of both ETA and ETB mediated blood pressure responses in rats. J Pharmacol Exp Ther 1994; 270: 728733.
  • 22
    Ohlstein EH, Nambi P, Douglas SA, Edwards RM, Gellai M, Lago A, Leber JD, et al. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist. Proc Natl Acad Sci U S A 1994; 91: 80528056.
  • 23
    Clozel M, Breu V, Gray GA, Kalina B, Loffler B-M, Burri K, Cassal J-M, et al. Pharmacological characterization of Bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 1994; 270: 228235.
  • 24
    Kusumoto K, Kubo K, Kandori H, Kitayoshi T, Sato S, Wakimatsu M, Watanabe T, et al. Effects of a new endothelin antagonist, TAK-044, on post-ischemic acute renal failure in rats. Life Sci 1994; 55: 301310.
  • 25
    Gellai M, Jugus M, Fletcher T, Nambi T, Ohlstein EH, Elliott JD, Brooks DP. Nonpeptide endothelin receptor antagonists V: prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther 1995; 275: 200206.
  • 26
    Watanabe T, Awane Y, Ikeda S, Fujiwara S, Kubo K, Kikuchi T, Kusumoto K, et al. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044, and the inhibition of myocardial infarct size in rats. Br J Pharmacol 1995; 114: 949954.
  • 27
    Richard V, Kaeffer N, Hogie M, Tron C, Blanc T, Thuillez C. Role of endogenous endothelin in myocardial and coronary endothelin injury after ischemia and reperfusion in rats: studies with bosentan, a mixed ETA-ETB antagonist. Br J Pharmacol 1994; 113: 869876.
  • 28
    Uhlig S, Bethmann AN, Featherstone RL, Wendel A. Pharmacologic characterization of endothelin receptor responses in the isolated perfused rat lung. Am J Respir Crit Care Med 1995; 152: 14491460.
  • 29
    Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC. Nonpeptide endothelin antagonist: cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 1994; 25: 24502456.
  • 30
    Nakamuta M, Takayanagi R, Sakai Y, Sakamoto S, Hagiwara H, Mizuno T, Saito Y, et al. Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor. Biochem Biophys Res Commun 1991; 177: 3439.
  • 31
    Takayanagi R, Ohnaka K, Takasaki C, Ohashi M, Nawata H. Multiple subtype of endothelin receptors in human and porcine tissues: characterization by ligand binding, affinity labeling, and regional distribution. J Cardiovasc Pharmacol 1991; 17 (suppl 7): S127S130.
  • 32
    Housset C, Rockey DC, Bissell DM. Endothelin receptors in rat liver: lipocytes as a contractile target for endothelin-1. Proc Natl Acad Sci U S A 1993; 90: 92669270.
  • 33
    Kawada N, Tran-Thi T, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Eur J Biochem 1993; 213: 815823.
  • 34
    Zhang JX, Pegoli W Jr, Clemens MG. Endothelin-1 induces direct constriction of hepatic sinusoids. Am J Physiol 1994; 266: G624G632.